Ageing is often viewed as an inevitable part of life, but David Sinclair, a leading researcher in the field, challenges this notion. At the inaugural Evolve Lecture Series held at UNIC Athens, Sinclair shared insights from his groundbreaking research on age reversal, captivating a full audience in the Andreas Vesalius Amphitheatre on June 4, 2026.
Photo: cyprus-mail.com
Redefining Ageing
Introducing Sinclair, Antonis Polemitis, CEO of the University of Nicosia, described him as a ‘super-exponential’ thinker, someone whose ideas are consistently ahead of their time. While UNIC aims to enhance healthy lifespan by a decade through preventive medicine, Sinclair aspires for even greater achievements: addressing ageing directly.
Photo: cyprus-mail.com
Ageing as the Root Cause
Sinclair’s core argument revolves around a revolutionary perspective on ageing. He claims that ageing is not merely a natural process but rather the underlying cause of many major diseases, including cancer, heart disease, and Alzheimer’s. By tackling ageing, which he refers to as ‘the mother of all diseases’, Sinclair believes that we can achieve significant health benefits.
The Information Theory of Ageing
During his lecture, Sinclair elaborated on his Information Theory of Ageing. He explained that the primary reason for cellular ageing is not damage to DNA but the loss of epigenetic instructions that govern cell behaviour—the ‘software’ of the cell. This concept challenges conventional wisdom and shifts the focus from merely repairing DNA to understanding how cellular identity is maintained.
From Lab to Human Trials
Sinclair’s journey is marked by notable discoveries, including his work on sirtuins and the essential role of NAD+. These findings paved the way for his laboratory’s epigenetic reprogramming experiments, which were a focal point of his talk. By employing three out of the four Yamanaka factors—deliberately omitting the fourth due to its cancer links—his team has successfully reset the age of cells, regrown damaged optic nerves, and restored sight in animal models.
Human Trials Begin
Excitingly, Sinclair revealed that this innovative approach has now reached the stage of human trials, conducted through his company, Life Biosciences. The trials commenced with urgent eye conditions, specifically glaucoma and NAION, a sudden-onset form of blindness. Sinclair announced that the first glaucoma patient has been treated, marking a significant milestone in the journey towards age reversal.
The Role of Artificial Intelligence
Sinclair also highlighted the transformative potential of artificial intelligence in accelerating research. He noted that tasks that would traditionally take over a century can now be accomplished in a single month, allowing researchers to screen billions of candidate molecules efficiently. This technological advancement promises to expedite breakthroughs not only for ocular conditions but also for other critical health issues such as liver diseases, motor neuron diseases like ALS, and cognitive decline.
Beyond Immortality: A Focus on Healthy Living
Despite the ambitious nature of his research, Sinclair is quick to clarify that he is not pursuing immortality. Instead, he aims to extend healthy years of life. As he articulated, “There is no law of biology that says we have to age.” This philosophy underpins his work and the work of many in the field of longevity research.
Engaging with the Audience
The lecture concluded with a vibrant discussion, where audience members engaged with Sinclair on various topics, from the funding and social challenges inherent in ageing research to the future possibility of regrowing organs and joints instead of replacing them. The exchange underscored the importance of collaboration and dialogue in advancing scientific frontiers.
The Evolve Lecture Series: A New Initiative
The event marked the beginning of the Evolve Lecture Series, an initiative by UNIC Athens designed to bring together leading scientists, researchers, and innovators to explore the cutting edges of artificial intelligence, robotics, biotechnology, and human health. This series derives its name and inspiration from Evolve, the university’s flagship research initiative that integrates nutrition, environment, human biology, and real-world data to develop new models for preventive and personalised medicine.
A Recognition of Excellence
In recognition of his exceptional contributions to ageing research and the science of longevity, the University of Nicosia conferred upon Professor David Sinclair the title of Honorary Doctor (Doctor of Philosophy Honoris Causa) on June 5, 2026. This accolade reflects both his pioneering work and the growing importance of the field in contemporary science.
